Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Mcguffog L

Collect these papers and discover other ones on Labmeeting. Learn more.

Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies.

+ cite this

+ View Abstract

Macinnis RJ, Antoniou AC, Eeles RA, Severi G, Guy M, McGuffog L, Hall AL, O'Brien LT, Wilkinson RA, Dearnaley DP, Ardern-Jones AT, Horwich A, Khoo VS, Parker CC, Huddart RA, McCredie MR,

(show remaining authors)

Genetic epidemiology 34(1):42-50, 2010 Jan - Who cited this? | PubMed ID: 19492347 | Fulltext

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).

+ cite this

+ View Abstract

Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S, KConFab, Neuhausen SL, Ding YC, Couch FJ, Wang X,

(show remaining authors)

British journal of cancer 101(12):2048-54, 2009 Dec 15 - Who cited this? | PubMed ID: 19920816 | Fulltext

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

+ cite this

+ View Abstract

Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Neuhausen SL, Ding YC, Couch FJ, Wang X, Fredericksen Z,

(show remaining authors)

Human molecular genetics 18(22):4442-56, 2009 Nov 15 - Who cited this? | PubMed ID: 19656774 | Fulltext

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

+ cite this

+ View Abstract

Sinilnikova OM, Antoniou AC, Simard J, Healey S, Léoné M, Sinnett D, Spurdle AB, Beesley J, Chen X, kConFab, Greene MH, Loud JT, Lejbkowicz F, Rennert G, Dishon S, Andrulis IL,

(show remaining authors)

British journal of cancer 101(8):1456-60, 2009 Oct 20 - Who cited this? | PubMed ID: 19707196 | Fulltext

No evidence that GATA3 rs570613 SNP modifies breast cancer risk.

+ cite this

+ View Abstract

Johnatty SE, Couch FJ, Fredericksen Z, Tarrell R, Spurdle AB, Beesley J, Chen X, kConFab Investigators, AOCS Group, Swedish BRCA1 and BRCA2 Study Collaborators, Gschwantler-Kaulich D, Singer CF, Fuerhauser C, Fink-Retter A, Domchek SM, Nathanson KL,

(show remaining authors)

Breast cancer research and treatment 117(2):371-9, 2009 Sep - Who cited this? | PubMed ID: 19082709 | Fulltext

An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers.

+ cite this

+ View Abstract

Osorio A, Pollán M, Pita G, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Preisler-Adams S, Niederacher D, Hofmann W, Gadzicki D, Jakubowska A, Hamann U, Lubinski J, Toloczko-Grabarek A,

(show remaining authors)

British journal of cancer 99(6):974, 2008 Sep 16 - Who cited this? | PubMed ID: 18781154 | Fulltext

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

+ cite this

+ View Abstract

Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D, Breast Cancer Susceptibility Collaboration (UK),

(show remaining authors)

Nature genetics 39(2):165-7, 2007 Feb - Who cited this? | PubMed ID: 17200668 | Fulltext

A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers.

+ cite this

+ View Abstract

Thompson D, Seal S, Schutte M, McGuffog L, Barfoot R, Renwick A, Eeles R, Sodha N, Houlston R, Shanley S, Klijn J, Wasielewski M, Chang-Claude J, Futreal PA, Weber BL, Nathanson KL,

(show remaining authors)

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 15(12):2542, 2006 Dec - Who cited this? | PubMed ID: 17164383 | Fulltext

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.

+ cite this

+ View Abstract

Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, Chagtai T, Jayatilake H, Ahmed M, Spanova K, North B, McGuffog L, Evans DG, Eccles D, Breast Cancer Susceptibility Collaboration (UK), Easton DF,

(show remaining authors)

Nature genetics 38(11):1239-41, 2006 Nov - Who cited this? | PubMed ID: 17033622 | Fulltext

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.

+ cite this

+ View Abstract

Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D, Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR,

(show remaining authors)

Nature genetics 38(8):873-5, 2006 Aug - Who cited this? | PubMed ID: 16832357 | Fulltext

A genome wide linkage search for breast cancer susceptibility genes.

+ cite this

+ View Abstract

Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, Chenevix-Trench G, kConFab Investigators, Szabo C, Southey M, Renard H, Odefrey F, Lynch H, Stoppa-Lyonnet D, Couch F, Hopper JL,

(show remaining authors)

Genes, chromosomes & cancer 45(7):646-55, 2006 Jul - Who cited this? | PubMed ID: 16575876 | Fulltext

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.

+ cite this

+ View Abstract

Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, Bishop T, Benitez J, Rivas C, Bignon YJ, Chang-Claude J, Hamann U, Cornelisse CJ, Devilee P, Beckmann MW, Nestle-Krämling C,

(show remaining authors)

Clinical cancer research : an official journal of the American Association for Cancer Research 11(14):5175-80, 2005 Jul 15 - Who cited this? | PubMed ID: 16033833 | Fulltext

Cancer risks and mortality in heterozygous ATM mutation carriers.

+ cite this

+ View Abstract

Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M, and Easton DF

Journal of the National Cancer Institute 97(11):813-22, 2005 Jun 1 - Who cited this? | PubMed ID: 15928302 | Fulltext

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.

+ cite this

+ View Abstract

Lakhani SR, Manek S, Penault-Llorca F, Flanagan A, Arnout L, Merrett S, McGuffog L, Steele D, Devilee P, Klijn JG, Meijers-Heijboer H, Radice P, Pilotti S, Nevanlinna H, Butzow R, Sobol H,

(show remaining authors)

Clinical cancer research : an official journal of the American Association for Cancer Research 10(7):2473-81, 2004 Apr 1 - Who cited this? | PubMed ID: 15073127 | Fulltext

Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.

+ cite this

+ View Abstract

Seal S, Barfoot R, Jayatilake H, Smith P, Renwick A, Bascombe L, McGuffog L, Evans DG, Eccles D, Easton DF, Stratton MR, Rahman N, and

Cancer research 63(24):8596, 2003 Dec 15 - Who cited this? | PubMed ID: 14695169 | Fulltext

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

+ cite this

+ View Abstract

Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L, and Easton DF

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20(9):2310-8, 2002 May 1 - Who cited this? | PubMed ID: 11981002 | Fulltext

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.

+ cite this

+ View Abstract

Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L,

(show remaining authors)

Nature genetics 31(1):55-9, 2002 May - Who cited this? | PubMed ID: 11967536 | Fulltext

The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.

+ cite this

+ View Abstract

Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van de Vijver MJ, Venter D, Freeman A, Antoniou A, McGuffog L, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S,

(show remaining authors)

Clinical cancer research : an official journal of the American Association for Cancer Research 6(3):782-9, 2000 Mar - Who cited this? | PubMed ID: 10741697 | Fulltext

Search Google Scholar for Mcguffog L

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.